“…In a second step, the type I enzymes PRMT1 (Lin et al, 1996), PRMT3 (Tang et al, 1998), CARM1/PRMT4 (Chen et al, 1999), PRMT6 (Frankel et al, 2002) and PRMT8 (Lee et al, 2005a;Sayegh et al, 2007) lead to the formation of asymmetric dimethylarginine, whereas the type II enzyme PRMT5 (Branscombe et al, 2001;Pollack et al, 1999) and possibly PRMT7 (Lee et al, 2005b;Miranda et al, 2004) lead to symmetric dimethylarginine. One more member of the PRMT family, PRMT2, was identified by sequence homology to the known enzymes (Katsanis et al, 1997), but has not been classified into a group, because no enzymatic activity has yet been demonstrated or substrates identified; nevertheless, PRMT2 acts as a coactivator in hormonedependent gene expression (Meyer et al, 2007;Qi et al, 2002). Recently, an additional arginine methyltransferase activity has been described for FBXO11 (Cook et al, 2006).…”